A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)

Condition:   Asthma Interventions:   Drug: BFF MDI 160/9.6 μg BID (320/19.2μg/day);   Drug: BD MDI 160 μg BID (320 μg/day) Sponsor:   AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials